Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.63 -0.18 (-3.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vanda Pharmaceuticals (VNDA) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Vanda Pharmaceuticals (VNDA) recorded Depreciation & Amortization (CF) of $267,000 in Q2 2026, unchanged from $267,000 a year earlier and down 2.2% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, Vanda Pharmaceuticals' Depreciation & Amortization (CF) came in at $1.15 million as of Jun 30, 2026, up 17.3% year-over-year; for FY2025, it came in at $1.1 million, up 22.6% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of -4.7% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $900,000 in FY2024 (-2.2%), $920,000 in FY2023 (-24.4%), $1.22 million in FY2022 (-13.1%) and $1.4 million in FY2021 (unchanged).
  • Quarterly Depreciation & Amortization (CF) has ranged from $200,000 in Q3 2023 to $374,000 in Q4 2021 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in seven of the last eight quarters, with growth averaging 18.1%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 39.4% in Q3 2025, against a decline of 33.1% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $273,000 (Q1 2026), $304,000 (Q4 2025) and $301,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Vanda Pharmaceuticals 279.91 Mn -650.03 Mn 46.97 Mn 267,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 267,000.00
Mar 31, 2026 273,000.00
Dec 31, 2025 304,000.00
Sep 30, 2025 301,000.00
Jun 30, 2025 267,000.00
Mar 31, 2025 231,000.00
Dec 31, 2024 262,000.00
Sep 30, 2024 216,000.00
Jun 30, 2024 216,000.00
Mar 31, 2024 206,000.00
Dec 31, 2023 205,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 224,000.00
Mar 31, 2023 291,000.00
Dec 31, 2022 284,000.00
Sep 30, 2022 299,000.00
Jun 30, 2022 311,000.00
Mar 31, 2022 323,000.00
Dec 31, 2021 374,000.00
Sep 30, 2021 338,000.00
API Access

Vanda Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VNDA&period=max&api_key=YOUR_API_KEY